PDF (Español (España))
FLIP
EPUB (Español (España))
XML (Español (España))
Manuscripts sent to SALUTA Magazine must be original and unpublished and must not be simultaneously in the process of publication in other magazines, compilations or any other means of publication. The content of the publications and the links suggested in them are the sole responsibility of the authors and not of the METROPOLITAN UNIVERSITY OF EDUCATION, SCIENCE AND TECHNOLOGY
(UMECIT) or the magazine SALUTA. They are protected by international copyright laws as well as the logos of UMECIT AND SALUTA MAGAZINE, hence their reproduction is totally prohibited. The copyright will belong to the UMECIT.
Under a Creative Commons Attribution License authors may share work with acknowledgment of authorship of the work and initial publication in this journal.
Abstract
The competence of the individual immune system is one of the factors that determines the ability to defend against SARS-CoV-2. Despite the high number of investigations that describe risk factors for greater severity and/or mortality such as age over 60 years, the presence of comorbidities or male sex, it continues to be important to identify factors that explain the wide clinical variability of this disease or as subjects exposed to the virus do not become infected. The objective was to evaluate the concentration of IgG against Tetanus and Diphtheria toxoids in patients recovered from COVID-19 and exposed first-degree relatives. A cross-sectional case-control study was carried out in which 1,131 serum samples corresponding to Cuban patients confirmed and recovered from COVID-19 and 493 exposed first-degree relatives were studied during the period from June to September 2020. The sample was divided into three age groups and two groups according to sex. The analysis was carried out in each group taking into account the degree of severity of COVID-19 reached by the patient during the infection. Concentrations of tetanus and diphtheria antitoxoids in serum were quantified using an indirect solid-phase immunoenzymatic assay. Results: 96.9% of female patients and 97.6% of male patients presented reliable long-lasting protective levels against tetanus toxin. Against diphtheria, the highest levels were reliable protection in the short term (68.2% women and 77.3% men). The cases recovered from the severe form of COVID-19 presented lower geometric mean levels of IgG against tetanus and diphtheria toxins than the control group. Conclusions: Serum ATD IgG levels of both sexes did not reach the level of reliable long-lasting protection. The CMG levels of IgG ATT and ATD varied in the different age groups depending on the status achieved by the patient during the course of the disease. These results demonstrate the need to strengthen the immune system of both people not affected by the viral infection and those affected.
References
Durán- García FA. Estrategia de enfrentamiento a la epidemia de COVID-19, Cuba, 2020. Rev Cub Sal Públ. 2022; 48 (4). http//revsaludpublica.sld.cu (2)
Fonte L, Ginori M, García G. COVID-19 ¿por qué los niños son menos susceptibles? Revista Cubana de Pediatría. 2020; 92: -1260. https://creativecommons.org/licenses/by-nc/4.0/deed.es'>https://creativecommons.org/licenses/by-nc/4.0/deed.es (30)
Frasca D, Blomberg BB. Aging affects human B cell responses. J Clin Immunol. 2011;10-9501-7. https://pubmed.ncbi.nlm.nih.gov/21318330/ (32)
García-Gutiérrez A, Gil-Osuna JD, Pimiento-Díaz M, Viveros-Enríquez JA, González-Clavijo AM. El elemento seXo en el COVID-19: mecanismos diferenciales en la susceptibilidad, la severidad y la mortalidad de la enfermedad por SARS-CoV-2. Rev Colomb Endocrinol Diabet Metab 2022; 9(4): e759. https://doi.org/10.53853/encr.9.4.759 (28)
Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick L. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. Med Rxiv 2020. https://doi.org/10.1101/2020.04.14.20065771 (25)
La Rosa D, Montesino S, Bezos L, Gómez E, Balmaceda T, Alerm A, Ochoa R. Lactancia materna y respuesta humoral contra vacunas de toxoide tetánico y diftérico en niños de 2 años. VacciMonitor. 2011; 20(3):9-13. http://scielo.sld.cu/pdf/vac/v20n3/vac02311.pdf'>http://scielo.sld.cu/pdf/vac/v20n3/vac02311.pdf (19)
Lee PI, Hu YL, Chen PY, Huang YC, ¿Hsueh PR. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020;53(3):371-2. doi: 10.1016/j.jmii.2020.02.011. (29)
León, López -Ponce JD, Cardena-Marin PA, Giraldo-González GC, Herrera-Escalona A. CORONAVIRUS–COVID 19: Más allá de la enfermedad pulmonar, qué es y qué sabemos del vínculo con el sistema cardiovascular. Rev. Colomb. Cardiol. [online]. 2020; 27(3):142-152. https://doi.org/10.1016/j.rccar.2020.04. (8)
Li X, Geng M, Peng Y, Meng L, Lu Sh. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharmaceutical Analysis. 2020;10(2):102-8. https://pubmed.ncbi.nlm.nih.gov/32282863/ (13)
López PGT, Ramírez MDLP, Torres MS. Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2. Rev Alergia, Asma e inmunología Pediátrica. 2020; 29, (1) 5-15. https://dx.doi.org/10.35366/93321 doi: 10.35366/93321 (9)
Lu X, Zhang L, Du H et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382 (17): 1663-1665. Available from. https://www.nejm.org/doi/pdf/10.1056/NEJMc2005073 (6)
Mizumoto K, Chowell G. Estimating risk for death from 2019novel coronavirus disease, China. Emerg Infect Dis. 2020; 26(6): 1251–1256. (26)
Mojica-Crespo R, Morales-Crespo MM. Pandemia COVID-19, la nueva emergencia sanitaria de preocupación internacional: una revisión. Semergen. 2020. https://doi.org/10.1016/j.semerg.2020.05.010 (3)
Nania R. Por qué la Covid -19 afecta más a los hombres que a las mujeres. [Internet]. [Inf- 2020. Disponible en: https://www.aarp.org'>https://www.aarp.org (21)
Ochoa R, Martínez JC, Ferriol X, Sotolongo F. Niveles de antitoxina tetánica y diftérica en recién nacidos y niños preescolares cubanos. Rev Cubana Med Trop 2006; 58(1):449. http://www.bvs.sld.cu/revistas/mtr/vol58_1_06/mtr08106.pdf (18)
Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY. Air surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from asymptomatic patient. JAMA. 2020;323(16):1610-2. Disponible en: https://10.1001/jama.2020.3227 (4)
PASTRIAN, S. G. Bases genéticas y moleculares del COVID-19 (SARS-CoV-2). Mecanismos de patogénesis y de respuesta inmune. Int. J. Odontostomat. 2020; 14(3):331-337. https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-381X2020000300331 (12)
Pérez- Cutiño M, Pardo- Martínez D, Acosta -Torres JR, Alonso- Remedios A. Aproximación a la dinámica de la respuesta inmune en la infección por la COVID-19. Rev Panorama. Cuba y Salud. 2020; 15(3):76-82. http://www.revpanorama.sld.cu/index.php/rpan/article/view/ (7)
Pérez –Fumero Y, Arce –Hernández AA, Macías- Abraham C. Respuesta de anticuerpos en la enfermedad por coronavirus 2019. Rev Cubana de Inmunología y Hemoterapia. 2020; 36: e1267. https://creativecom m ons.org/licenses/b y - nc/4.0/deed. (11)
Plikaytis BD, Carlone GM. Program ELISA for Windows User’s Manual, version 2. Centers for Disease Control and Prevention, Atlanta, GA, U.S.A., 2005. (17)
Puig –Menese Y. Estudio sociodemográfico, también para entender el comportamiento de la Covid-19. Periodico Gramma. 2020. http//www.granma.cu (20)
Rachel Nania. Por qué la Covid -19 afecta más a los hombres que a las mujeres. Inf- 2020 https://www.aarp. (27)
Rodríguez- Lay l, Tejero -Suarez Y, pelegrino JL, Morales- Verdecía DD, Montalvo -Villalba MC, Valdés O, Resik S, Guzmán MG. Evaluación de ensayos ultramicroanalíticos para la detección de anticuerpos contra el SARS-CoV-2. Revista Cubana de Medicina Tropical. 2022; 74(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602022000100003'>http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602022000100003 (14)
Rodríguez- Pelier CV, Martínez -Téllez G, Torres -Rives B, Zúñiga -Rosales Y, Alles -Gustavo A, Martínez- Perera A. Estandarización y validación de un ELISA para la cuantificación de antitoxina tetánica en suero humano. Revista Habanera de Ciencias Médicas 2013;12(4). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/246 (15)
Rodríguez- Pelier CV, Zúñiga- Rosales Y, Torres -Rives B, Matarán -Valdés M. Validación de un ensayo inmunoenzimático tipo ELISA para cuantificar niveles de antitoxina diftérica en suero humano. Revista Habanera de Ciencias Médicas 2018; 17(4):527-539. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2113 (16)
Romo DKJ y cols. Manifestaciones clínicas de la COVID-19. Rev Latin Infect Pediatr. 2020; 33 (1): 10-32. https://www.medigraphic.com/pdfs/infectologia/lip-2020/lips201c. (5)
Saavedra D, García B. Inmunosenescencia: efectos de la edad sobre el sistema inmune.Revista Cubana de Hematol, Inmunol y Hemoter. 2014;30(4):332-345. http://scielo.sld.cu (31)
Suárez- R eyes AM, Villegas –Valdeverde CA . Características y especialización de la respuesta inmunitaria en la COVID-19. Rev de la Facultad de Medicina de la UNAM]. 2020; 63(4) lookhttp://doi.org/10.22201/fm.24484865e.2020.63.4.02 (10)
Tan W, Lu Y, Zhang J, Wang J, Dan Y, Tan Z, et al. Viral Kinetics and Antibody Responses in Patients with COVID-19. ClinInfectDis. 2020 Mar 28; ciaa344. doi: https://10.1093/cid/ciaa344. (24)
Wan ZY, Zhang X, Yan XG. IFA in testing specific antibody of SARS coronavirus. South China J Prev Med. 2003; 29(3):36‐7. (23)
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Med Rxiv preprint. 2020 https://doi.org/10.1101/2020.03.02.20030189 (22)
